Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls

被引:44
作者
Bambha, K [1 ]
Kim, WR [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
cost-effectiveness; economic analysis; incremental cost-effectiveness ratio; costs; sensitivity analysis; discounting; health care costs;
D O I
10.1097/00042737-200406000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cost-effectiveness analysis is a formal method of comparing alternative medical interventions with regard to their resource utilization (costs) and outcomes (effectiveness). The incremental cost-effectiveness ratio is an informative measure generated from such an analysis and represents the ratio of the difference in cost between two medical interventions to the difference in outcomes between the two interventions. Thus, the incremental cost-effectiveness ratio summarizes the additional cost per unit of health benefit gained in switching from one medical intervention to another. Although incremental cost-effectiveness ratios have limitations, when used in the proper context, these ratios serve as one of the important tools needed to help guide decisions about allocating scarce resources across competing medical programmes. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 50 条
  • [1] A cceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold
    Griffiths, Elizabeth A.
    Hendrich, Janek K.
    Stoddart, Samuel D. R.
    Walsh, Sean C. M.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 463 - 476
  • [2] Incremental cost-effectiveness ratios (ICERs): The silence of the lambda
    Gafni, A
    Birch, S
    SOCIAL SCIENCE & MEDICINE, 2006, 62 (09) : 2091 - 2100
  • [3] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
  • [4] COST-EFFECTIVENESS ANALYSIS - IS IT ETHICAL
    WILLIAMS, A
    JOURNAL OF MEDICAL ETHICS, 1992, 18 (01) : 7 - 11
  • [5] COST-EFFECTIVENESS RATIOS - IN A LEAGUE OF THEIR OWN
    BIRCH, S
    GAFNI, A
    HEALTH POLICY, 1994, 28 (02) : 133 - 141
  • [6] Bayesian cost-effectiveness analysis with two measures of effectiveness:: the cost-effectiveness acceptability plane
    Negrín, MA
    Vázquez-Polo, FJ
    HEALTH ECONOMICS, 2006, 15 (04) : 363 - 372
  • [7] Incremental Cost-Effectiveness Ratios (ICERs) and Revised Metformin Cost-Effectiveness Conclusions in the Diabetes Prevention Program/ Diabetes Prevention Program Outcomes Study
    Alolayan, Sultan
    Eguale, Tewodros
    Segal, Alissa R.
    Doucette, Joanne
    Rittenhouse, Brian E.
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2025,
  • [8] Statistical primer: a cost-effectiveness analysis
    Antonides, Christiaan F. J.
    Cohen, David J.
    Osnabrugge, Ruben L. J.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 54 (02) : 209 - 213
  • [9] Ethical issues in cost-effectiveness analysis
    Pinkerton, SD
    Johnson-Masotti, AP
    Derse, A
    Layde, PM
    EVALUATION AND PROGRAM PLANNING, 2002, 25 (01) : 71 - 83
  • [10] Cost-effectiveness analysis in radiology
    Singer, ME
    Applegate, KE
    RADIOLOGY, 2001, 219 (03) : 611 - 620